UBS analyst John Hodulik raised the firm’s price target on Charter (CHTR) to $385 from $325. The firm keeps a Neutral rating on the shares given sustained competition and the expectation for slowing EBITDA growth in 2025, the analyst tells investors in a research note. UBS expects similar EBITDA growth in Q4 as the benefit of price increases and high-margin political ad is partly offset by hurricane impact, but sees a more challenging backdrop for 25 as political ad unwinds and competitive pressures remain.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHTR: